Results 141 to 150 of about 771,983 (316)

Nanocarrier‐Based Targeting of Pattern Recognition Receptors as an Innovative Strategy for Enhancing Sepsis Therapy

Advanced Healthcare Materials, EarlyView.
This review highlights recent progress in nanocarriers targeting pattern recognition receptors (PRRs), including Toll‐like and NOD‐like receptors, for enhancing the treatment of bacterial sepsis and related complications. These nanomedicines deliver antibiotics and anti‐inflammatory agents while modulating immune responses.
Eman A. Ismail, Vincent O. Nyandoro, Calvin A. Omolo, Thirumala Govender   +3 more
wiley   +1 more source

Optimizing a human monoclonal antibody for better neutralization of SARS-CoV-2. [PDF]

Nat Commun
Wang Q, Guo Y, Casner RG, Yu J, Nair MS, Ho J, Reddem ER, Mellis IA, Wu M, Tzang CC, Hong H, Huang Y, Shapiro L, Liu L, Ho DD.   +14 more
europepmc   +1 more source

Production and characterization of a monoclonal antibody that binds Reed-Sternberg cells. [PDF]

, 1985
Th. Hecht, Dan L. Longo, Jeffrey Cossman, Joseph B. Bolen, S M Hsu, Mônica Simões Israel, Richard I. Fisher   +6 more
openalex   +1 more source

Differential Phase Contrast Imaging to Predict MSC Immune Function

Advanced Healthcare Materials, EarlyView.
This work employs quantitative differential phase contrast (qDPC) imaging technique to non‐invasively extract morphological features from live Mesenchymal Stromal Cells (MSCs) for single cell prediction on cell immunomodulatory capacity. This work establishes a foundation for scalable, non‐destructive monitoring of MSCs immunomodulatory capacity ...
Kejie Rui, Priyanka Priyadarshani, Adrian Ross Liversage, Carlos Munoz, Steven Stice, Luke J. Mortensen   +5 more
wiley   +1 more source

Cancer therapy via neoepitope-specific monoclonal antibody cocktails. [PDF]

Cancer Immunol Immunother
Hartman CJ, Mohamed AO, Shukla GS, Pero SC, Sun YJ, Rodríguez-Jimenez RS, Genovese NF, Kohler NM, Hemphill TR, Huang YH, Krag DN, Ackerman ME.   +11 more
europepmc   +1 more source

Treatment with anti-L3T4 (CD4) monoclonal antibody reduces the inflammatory response in toxoplasmic encephalitis. [PDF]

, 1989
Dennis Israelski, Fausto G. Araujo, Frances K. Conley, Yutaro Suzuki, Shalini Sharma, J S Remington   +5 more
openalex   +1 more source

Immunosuppressive Cytokine‐Tethered Hydrogel for Treating Rheumatoid Arthritis

Advanced Healthcare Materials, EarlyView.
An injectable hydrogel is developed by chemically tethering IL‐4, an immunosuppressive cytokine, to a hyaluronic acid‐based backbone. The hydrogel reduces joint friction and exerts immunomodulatory effects. In a rheumatoid arthritis (RA) mouse model, it reduced inflammation, preserved cartilage, and promoted anti‐inflammatory immune responses.
Woojin Back, Moonkyoung Jeong, Huyen‐Thao Le, Ji‐Ho Park   +3 more
wiley   +1 more source

Research trends in anti-rabies virus monoclonal antibody: A bibliometric analysis. [PDF]

Hum Vaccin Immunother
Liu C, Lv X, Liu S, Chen Q, Zhu Z, Yu R, Yin W, Wang C.   +7 more
europepmc   +1 more source

Identification and characterization of a monoclonal antibody recognizing a galactose-binding domain of the toxin ricin. [PDF]

, 1987
Marco Colombatti, V G Johnson, Hal A. Skopicki, B Fendley, MaryAnn. Lewis, Richard J. Youle   +5 more
openalex   +1 more source

3D Bioprinted Renal Constructs Using Kidney‐Specific ECM Bioink System on Kidney Regeneration

Advanced Healthcare Materials, EarlyView.
A kidney‐specific bioink derived from decellularized porcine kidney tissue supports the encapsulation, viability, and maturation of human primary kidney cells within 3D bioprinted constructs. In vivo, it also promotes the recruitment of host renal progenitor cells, collectively enhancing structural and functional regeneration of renal tissue.
Gabriel Carreno‐Galeano, Mohamed Ali, James J. Yoo, Sang Jin Lee, Anthony Atala   +4 more
wiley   +1 more source